Amarin Corp Plc (AMRN)

[VuBru]

Kiwi - Normally in a clinical trial, patients have to agree to stay on the same treatment regimen (at least CV related in a study like this) that they were on at study outset throughout their trial participation - this is done because of potential confounds over time for exactly the reason you noted. If people want to try other new treatments, they would normally have to drop out of the study. Some may do so outside of teh study but I do not think this would affect a large proportion of patients, especially those in countries where newer drugs may not be available, approved, or affordable.